Neurological Manifestations of Wegener's Granulomatosis - Case Report
DOI:
https://doi.org/10.3889/oamjms.2025.12024Keywords:
polyangiitis, granulomatosis, neuropathyAbstract
BACKGROUND: Granulomatosis with polyangiitis is an inflammatory process that affects the endothelium of small and medium blood vessels. It is an autoimmune disease, which is systemic and attacks multiple organ systems. It is also called Wegener's granulomatosis (Wegener Granulomatosis), according to the German pathologist Wegener who described the first cases of granulomatous inflammation of small and medium blood vessels.
CASE PRESENTATION: This paper presents a clinical case report of a middle-aged female patient with Wegener's granulomatosis, treated at the Department of Neurology at City General Hospital 8th September. The patient's initial symptoms began nine years ago. The course of her disease is chronic with a progressive nature, followed by relapses and exacerbations. The patient was promptly diagnosed and treated with appropriate therapy, which she tolerates well. The definitive diagnosis is established by biopsy of the affected tissue and pathohistological analysis, where the presence of granulomas is detected.
CONCLUSION: This form of polyangiitis is significant for the presence of anti-neutrophil cytoplasmic antibodies (ANCA) in the patient's blood. But their absence does not exclude the disease. In terms of therapy, drugs are used that regulate the patient's immune system. We must be aware of the risk of complications and worsening of the course of the disease. This condition requires a multidisciplinary approach to treatment.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Olivencia-Simmons I. Wegener's granulomatosis: symptoms, diagnosis, and treatment. Journal of the American Association of Nurse Practitioners. 2007 Jun 1;19(6):315-20. https://doi.org/10.1111/j.1745-7599.2007.00231.x PMid:17535341 DOI: https://doi.org/10.1111/j.1745-7599.2007.00231.x
Unizony S, Villarreal M, Miloslavsky EM, Lu N, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CM, Clair EW. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type. Annals of the rheumatic diseases. 2016 Jun 1;75(6):1166-9. https://doi.org/10.1136/annrheumdis-2015-208073 PMid:26621483 PMCid:PMC4908815 DOI: https://doi.org/10.1136/annrheumdis-2015-208073
Rasmussen N. SP0065 The 2012 revised international chapel hill consensus conference nomenclature of the vasculitides. Annals of the Rheumatic Diseases. 2012 Jun 1;71:16. https://doi.org/10.1136/annrheumdis-2012-eular.1540 DOI: https://doi.org/10.1136/annrheumdis-2012-eular.1540
Hoffman GS. "Wegener's granulomatosis": the path traveled since 1931. Medicine. 1994 Nov 1;73(6):325-9. https://doi.org/10.1097/00005792-199411000-00006 PMid:7984084 DOI: https://doi.org/10.1097/00005792-199411000-00006
Khodosh E. The Role of Conceptual Views in the Diagnostics of Systemic Vasculitis and Granulomatosis with Polyangiitis. EC Pulmonology and Respiratory Medicine. 2023;12:51-64.
Fahey JL, Leonard E, Churg J, Godman G. Wegener's granulomatosis. The American journal of medicine. 1954 Aug 1;17(2):168-79. https://doi.org/10.1016/0002-9343(54)90255-7 PMid:13180525 DOI: https://doi.org/10.1016/0002-9343(54)90255-7
Nishino H, Rubino FA, DeRemee RA, Swanson JW, Parisi JE. Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society. 1993 Jan;33(1):4-9. https://doi.org/10.1002/ana.410330103 PMid:8388187 DOI: https://doi.org/10.1002/ana.410330103
Kubaisi B, Samra KA, Foster CS. Granulomatosis with polyangiitis (Wegener's disease): An updated review of ocular disease manifestations. Intractable & rare diseases research. 2016;5(2):61-9. https://doi.org/10.5582/irdr.2016.01014 PMid:27195187 PMCid:PMC4869584 DOI: https://doi.org/10.5582/irdr.2016.01014
Tarabishy AB, Schulte M, Papaliodis GN, Hoffman GS. Wegener's granulomatosis: clinical manifestations, differential diagnosis, and management of ocular and systemic disease. Survey of ophthalmology. 2010 Sep 1;55(5):429-44. https://doi.org/10.1016/j.survophthal.2009.12.003 PMid:20638092 DOI: https://doi.org/10.1016/j.survophthal.2009.12.003
Sarraf P, Sneller MC. Pathogenesis of Wegener's granulomatosis: current concepts. Expert Reviews in Molecular Medicine. 2005 May;7(8):1-9. https://doi.org/10.1017/S146239940500921X PMid:15890083 DOI: https://doi.org/10.1017/S146239940500921X
Fauci AS, Haynes BF, Watz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Annals of internal medicine. 1983 Jan 1;98(1):76-85. https://doi.org/10.7326/0003-4819-98-1-76 PMid:6336643 DOI: https://doi.org/10.7326/0003-4819-98-1-76
Sakurazawa M, Katsumata T, Kunugi S, Katsura KI, Sakamoto S, Katayama Y. Case report of Wegener's granulomatosis presenting with multiple cranial nerve palsy and hypertrophic cranial pachymeningitis. Rinsho Shinkeigaku= Clinical Neurology. 2007 Feb 1;47(2-3):85-9.
Ujjawal R, Koushik P, Ajay P, Subrata C. A case of Wegener's granulomatosis presenting with unilateral facial nerve palsy. Case Reports in Medicine. 2016;2016(1):9153625. https://doi.org/10.1155/2016/9153625 PMid:27110249 PMCid:PMC4823487 DOI: https://doi.org/10.1155/2016/9153625
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Bojana Kacarova, Daniela Ristic-Stomnaroska (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0)
